
|Articles|April 27, 2003
Urine evaluation recommended for recurrent stone formers
The UroRisk Diagnostic Profile from Mission Pharmacal is available forurine metabolic evaluation of renal stone disease. This test is recommendedfor initial and recurrent stone formers and those who do not test positivefor urinary tract infection. UroRisk is a semi-comprehensive evaluationthat measures nine risk factors for stone formation, the company says. Testresults are reported on an easy-to-read graphic display.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: Adjuvant Therapy in Renal Cell Carcinoma, with Brian Shuch, MD
2
FDA approves sildenafil oral film for men with erectile dysfunction
3
Head-to-head analysis shows OS benefit with apalutamide vs darolutamide in mCSPC
4
URO-1 prostate biopsy devices adopted across Novant Health System as clinical study continues
5






